Now Approved: U.S. FDA approves product to reduce the incidence of catheter-related bloodstream infections (CRBSIs) under special pathway for patients receiving hemodialysis.

CorMedix Inc. To Present at the H.C Wainwright 22nd Annual Global Investment Conference

September 5, 2022